Adenovirus-mediated Calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: Bifunctional therapeutic effects on peritoneal cell layer and cancer cells

Clinical Cancer Research

Volumn 12, Issue 17, 2006, Pages 5216-5223

  Ogura, Tomonori ^a   Kobayashi, Hiroaki ^a   Ueoka, Yousuke ^a   Okugawa, Kaoru ^a   Kato, Kiyoko ^b   Hirakawa, Toshio ^a   Hashimoto, Shigenari ^c,d   Taniguchi, Shun'ichiro ^d   Wake, Norio ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; PACLITAXEL;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL CULTURE; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROFILAMENT PROTEINS; OVARIAN NEOPLASMS; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33749028996     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0674     Document Type: Article

References (22)

1. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
2. Takahashi K, Hiwada K, Kokubu T. Isolation and characterization of a 34,000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle. Biochem Biophys Res Commun 1986;141:20-6.
3. Strasser P, Gimona M, Moessler H, Herzog M, Small JV. Mammalian calponin. Identification and expression of genetic variants. FEBS Lett 1993;330:13-8.
4. Applegate D, Feng W, Green RS, Taubman MB. Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. J Biol Chem 1994;269:10683-90.
5. Trabelsi-Terzidis H, Fattoum A, Represa A, Dessi F, Ben-Ari Y, der Terrossian E. Expression of an acidic isoform of calponin in rat brain: Western blots on one- or two-dimensional gels and immunolocalization in cultured cells. Biochem J 1995;306:211-5.
6. Childs TJ, Watson MH, Novy RE, Lin JJ, Mak AS. Calponin and tropomyosin interactions. Biochem Biophys Acta 1992;1121:41-6.
7. Graceffa P. Evidence for interaction between smooth muscle tropomyosin and caldesmon. FEBS Lett 1987;218:139-42.
8. Winder SJ, Walsh MP. Calponin: thin filament-linked regulation of smooth muscle contraction. Cell Signal 1993;5:677-86.
9. Shirinsky VP, Biryukov KG, Hettasch JM, Sellers JR. Inhibition of the relative movement of actin and myosin by caldesmon and calponin. J Biol Chem 1992;267:15886-92.
10. Noda S, Ito M, Watanabe S, Takahashi K, Maruyama K. Conformational changes of actin induced by calponin. Biochem Biophys Res Commun 1992;185:481-7.
11. Kobayashi H, Tsuruchi N, Sugihara K, et al. Expression of α-smooth muscle actin in benign or malignant ovarian tumors. Gynecol Oncol 1993;48:308-13.
12. Okamoto-Inoue M, Nakayama J, Hori Y, Taniguchi S. Human malignant melanoma cells release a factor that inhibits the expression of smooth muscle α-actin. J Dermatol Sci 2000;23:170-7.
13. Sobue K, Sellers JR. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 1991;266:12115-8.
14. Taniguchi S, Takeoka M, Ehara T, et al. Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res 2001;61:7627-34.
15. Hashimoto S, Takeoka M, Taniguchi S. Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells. Int J Cancer 2003;107:557-63.
16. Horiuchi A, Nikaido T, Taniguchi S, Fujii S. Possible role of calponin hi as a tumor suppressor in human uterine leiomyosarcoma. J Natl Cancer Inst 1999;91:790-6.
17. Takeoka M, Ehara T, Sagara J, Hashimoto S, Taniguchi S. Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells. Eur J Cancer 2002;38:436-42.
18. Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res 1999;59:5822-9.
19. Ueoka Y, Kato K, Wake N. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway. Mol Cell Endocrinol 2003;202:81-8.
20. Kobayashi H, Moniwa N, Gotoh J, Sugimura M, Terao T. Role of activated protein C in facilitating basement membrane invasion by tumor cells. Cancer Res 1994;54:261-7.
21. Gimona M, Kaverina I, Resch GP, Vignal E, Burgstaller G. Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 2003;14:2482-91.
22. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994;1:395-402.